Dr. Reddy's recalls blood pressure drug


India's Dr. Reddy's Laboratories (RDY) recalls 13,560 bottles of metoprolol succinate, a drug for high blood pressure, after it failed a dissolution test, a measure to check the amount of time it takes the active ingredient to release into the body which helps predict the drug's performance inside the body. The FDA classifies the recall as Class II which means that use or exposure may cause temporary or medically reversible health consequences.

Metoprolol succinate extended release is a generic form of AstraZeneca's (AZN) Toprol XL. Wockhardt Ltd recalled 109,744 bottles of the same drug last month also for failing a dissolution test.

In March, Dr. Reddy's recalled 58,656 bottles of the heartburn drug lansoprazole due to microbial contamination. Indian drug makers have been hit by numerous quality issues this year which has prompted increased scrutiny from regulators.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs